Rodman & Renshaw initiated coverage on Rein Therapeutics with a new price target

1/28/25 7:16:42 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Rodman & Renshaw initiated coverage of Rein Therapeutics with a rating of Buy and set a new price target of $8.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$RNTX

Date	Price Target	Rating	Analyst
1/28/2025	$8.00	Buy	Rodman & Renshaw